We found that SB939 corrects BIM pre-mRNA splicing in CML cells with the BIM deletion polymorphism, and induces apoptotic cell death in CML cell lines and primary cells with the BIM deletion polymorphism. This evidence concerns the gene BCL2L11 and chronic myelogenous leukemia, BCR-ABL1 positive.